In Brief
Candida albicans is a dimorphic fungus responsible for chronic mucocutaneous and systemic infections. Kaplan and colleagues demonstrate in a skin infection model that yeast forms induce skin-protective Th17 cell responses by driving Langerhans cell expression of interleukin-6. Filamentous forms induce Th1 cell responses that provide protection from systemic infection.
INTRODUCTION
Candida albicans is a human commensal and a common mucosal and systemic pathogen in the setting of immunosuppression. Chronic mucocutaneous candidiasis (CMC) occurs in the absence of innate sources of interleukin-17 (IL-17) and IL-22 as well as in the setting of ineffective T helper 17 (Th17) cell-type immunity in both mice and humans (e.g., HIV/AIDS or hyper IgE syndrome) (Herná ndez-Santos et al., 2013; McDonald, 2012; Murray et al., 1985) . CMC is also associated with mutations in the fungal recognition C-type lectin receptor Dectin-1 or its downstream signaling molecules (Ferwerda et al., 2009; Glocker et al., 2009 ). In contrast, systemic candidiasis predominantly occurs in the clinical setting of neutropenia and in mice with innate immune defects (e.g., Il6
À/À mice) resulting in ineffective neutrophil activation but does not occur in the absence of Th17-cell-associated or adaptive immunity (Bä r et al., 2014; Horn et al., 2009; van de Veerdonk et al., 2010; van Enckevort et al., 1999) . C. albicans is dimorphic and grows as yeast at 30 C and as a filamentous or hyphal form at 37 C. On the stratum corneum of the skin, C. albicans exists as budding yeasts. Pathogenic C. albicans in the dermis and systemic organs exists predominantly as pseudo-hyphae (Gow et al., 2012) . C. albicans mutants that are unable to form filaments fail to establish robust infections, suggesting that the yeast-to-hyphal transition is required for virulence (Lo et al., 1997) . This transition has also been suggested to be required for the development of anti-Candida Th17 cell responses, thereby allowing for discrimination between commensal and invasive C. albicans (Gow et al., 2012) . In vitro, C. albicans pseudo-hyphae induce Dectin-1-mediated Th17 cell differentiation (Cheng et al., 2011) . C. albicans pseudohyphae, however, have also been reported to promote Th1 and Th2 cell differentiation in vitro (d 'Ostiani et al., 2000; van der Graaf et al., 2005) . Importantly, T helper (Th) cell responses in vivo to yeast and filamentous forms of C. albicans and the ability of these adaptive responses to provide protection remain unclear.
In the skin, there are at least three well-defined subsets of dendritic cells (DCs): epidermal Langerhans cells (LCs), CD103 + dermal DC (dDCs), and CD11b + dDCs (Kaplan, 2010) . These DC subsets migrate from the skin into regional lymph nodes during infection where they present antigen to naive T cells and secrete cytokines that determine Th cell differentiation (Reis e Sousa, 2004) . During epicutaneous infection with C. albicans, CD103 + dDCs generate IL-12 and are required for differentiation of Th1 cells (Igyá rtó et al., 2011) . LCs are required for Th17 cell differentiation and express high amounts of Th17-cell-inducing cytokines IL-1b, transforming growth factor-b (TGF-b), and IL-6. The importance of individual cytokines in generating Th17 cells in vivo is controversial and varies by tissue. It has been demonstrated that IL-1b and IL-6 are both necessary for Th17 cell differentiation in peripheral tissues including skin (Hu et al., 2011) . Th17 cell induction in the spleen is independent of IL-6 but not IL-1b. In the intestines, several studies have confirmed an IL-1b dependence for Th17 cell development although the requirement for IL-6 remains controversial (Hu et al., 2011; Persson et al., 2013; Shaw et al., 2012) . CD11b + dDCs make up the majority of the skin migratory DCs and drive Th2 cell differentiation in the setting of dermal papain injection or parasitic infection (Gao et al., 2013; Kumamoto et al., 2013) . In the setting of C. albicans infection, this DC subset generates high amounts of IL-1b and to a lesser extent IL-6 and IL-12 (Igyá rtó et al., 2011) . Their ability, however, to promote Th cell differentiation other than Th2 cell differentiation remains unexplored (Kumamoto et al., 2013) . Based on the functional differences between skin DC subsets and the transition of C. albicans from yeast to filamentous forms during epidermal invasion, we hypothesized that DC subsets and C. albicans morphology together determine Th cell differentiation. Because of the requirement for immunosuppression to establish robust and consistent oropharyngeal C. albicans infection, we have focused on epicutaneous C. albicans infection. We found that infection with C. albicans yeast but not pseudohyphae was capable of inducing Th17 cell responses through a mechanism that required interaction with LCs, engagement of Dectin-1, and LC-derived IL-6. C. albicans in the dermis failed to induce Th17 cell differentiation despite the expression of Dectin-1 on CD11b + dDCs due to the absence of Dectin-1 ligation by pseudo-hyphae that are the dominant morphology at that site. Finally, we demonstrated that Th17 but not Th1 cells were protective against secondary cutaneous infections whereas Th1 but not Th17 cells were protective against secondary systemic infections. Thus, C. albicans morphology and skin DC subsets drive distinct Th cell responses that provide protection from either cutaneous or systemic infections.
RESULTS

Distinct T Helper Cell Responses Mediated by C. albicans Morphology
We have previously generated recombinant C. albicans derived from the standard SC5314 strain that expresses the peptides 2W1S and Ea, under the ubiquitous Eno1 promoter (Eno1-Ag). Using a TEa CD4 + T cell adoptive transfer system, we showed that mice that express diphtheria toxin fragment A (DTA) under a human Langerin (huLangerin) promoter with a constitutive absence of LCs (henceforth referred to as LC À ) failed to generate antigen-specific Th17 cells (Igyá rtó et al., 2011) . To exclude the possibility that this phenotype resulted from a chronic absence of LCs, we repeated these experiments with mice that express the diphtheria toxin receptor (DTR) within huLangerin (referred to has huLangerin-DTR mice) that allow for inducible ablation of LCs (Bobr et al., 2010) . As expected, ablation of LCs just prior to Eno1-Ag infection also prevented efficient Th17 cell differentiation ( Figure S1A ). We next examined the responses of endogenous antigen-specific CD4 + T cells to C. albicans by using I-A b :p2W1S tetramer staining 8 days after infection. Expansion of p2W1S-specific cells was equivalent in control and LCdeficient mice ( Figure 1A ). Expansion of cells producing IL-17A but not interferon-g (IFN-g), however, was significantly reduced in LC-deficient mice ( Figure 1B) . Thus, consistent with our earlier observations using adoptive transfer of T cell receptor (TCR) transgenic T cells specific for Ea (TEa), LCs are required for efficient differentiation of endogenous naive CD4 + T cells into Th17 cells. To determine whether recognition by LCs of yeast or filamentous forms of C. albicans affects Th cell differentiation, we selectively targeted antigen to LCs by i.p. injection of 1.0 mg anti-huLangerin mAb-Ea conjugates (2G3-Ea) in human Langerin transgenic mice (huLangerin) ( Figure S1B ; Flamar et al., 2012; Igyá rtó et al., 2011; Kaplan et al., 2012) . HuLangerin is expressed exclusively by LCs in these mice, resulting in efficient and LC-selective acquisition of 2G3-Ea. As a source of adjuvant, we epicutaneously infected 2G3-Ea-targeted huLangerin mice with wild-type SC5314 as well as cph/cph and tup1/tup1 mutants derived from SC5314 that are locked into yeast or hyphal forms, respectively (Braun and Johnson, 1997; Liu et al., 1994) . Expansion of adoptively transferred TEa cells was equivalent in mice infected with all three strains ( Figure 1C) . Notably, Th17 cell differentiation was intact in the mice infected with the yeast-locked cph1 mutant but was absent in those infected with the filament-locked tup1 mutant, suggesting that LCmediated Th17 cell differentiation requires the presence of C. albicans yeast forms ( Figure 1D) .
To determine the effect of C. albicans morphology under conditions in which antigen presentation is not limited to LCs, we next generated recombinant C. albicans in which expression of a fusion protein of GFP with the antigens Ea and 2W1S was driven by the promoter for the pseudo-hyphae-specific gene Hwp1 (Hwp1-Ag) (Staab et al., 1999) . Unlike Eno1-Ag where GFP expression was present in all C. albicans morphologies, expression of GFP by Hwp1-Ag was absent in yeast and observed only for filamentous forms . Both Eno1-Ag and Hwp1-Ag strains demonstrated similar virulence in vivo after epicutaneous or intravenous infection ( Figure S2F and S2G). Epicutaneous infection of WT mice with Eno1-Ag and Hwp1-Ag induced similar antigen-specific CD4 + T cells expansion and Th1 cell differentiation ( Figure 1F) . Notably, mice infected with Hwp1-Ag failed to efficiently induce Th17-cell-associated responses ( Figure 1G ). Thus, LCs and C. albicans yeast but not pseudo-hyphae are required for optimal Th17 cell differentiation.
Th17 Cell Differentiation Requires LC-Derived IL-6
In vitro, Th17 cell differentiation of naive cells requires combinations of IL-1b, IL-6, IL-23, and TGF-b (Chung et al., 2009; Ivanov et al., 2006; Zú ñ iga et al., 2013) . The requirement for IL-1b and IL-6 in vivo differs based on the site of immunization (Hu et al., 2011; Shaw et al., 2012) . To determine which cytokines are responsible for LC-mediated Th17 cell induction, we first compared responses in IL-1b-and IL-6-deficient mice. We found that both IL-1b and IL-6 deficiency resulted in diminished Th17 cell responses (Figures 2A and 2B) . Notably, Th17 cells were entirely absent in Il6 À/À mice and was associated with a reciprocal increase in Th1 cells (Figures 2B and 2C) . Because LCs express of IL-1b, TGF-b, and IL-6 during C. albicans infection (Igyá rtó et al., 2011), we next sought to determine which cytokines were required for Th17 cell differentiation. To generate LC-specific ablation of TGF-b1, we used huLangerin-cre ER-T2 Tgfb1 f/f mice that efficiently and selectively excise TGF-b1 in LCs after administration of tamoxifen . We have previously reported that ablation of TGFb1 in LCs results in a gradual spontaneous migration of LCs out of the epidermis over the course of weeks. To avoid this potential confounding factor, we infected mice on day 5 after tamoxifen administration, a time point when TGF-b has been efficiently excised but LCs have not begun to migrate in large numbers. As controls, we also infected tamoxifen-treated huLangerin-cre ER-T2 YFP and huLangerin-cre ER-T2 Tgfbr2 f/f mice, which maintain TGF-b expression but also have increased homeostatic migration . Antigen-specific T cell expansion and Th cell phenotype differentiation was equivalent in all three strains, demonstrating that LC-derived TGF-b is not required for Th17 cell differentiation ( Figures 3A and 3B ).
To generate LC-specific ablation of IL-1b and IL-6, we generated WT/Il1b À/À and WT/Il6 À/À bone marrow chimeras. LCs are the only radio-resistant antigen-presenting cells (APCs) in the skin and remained of cytokine-deficient host origin while the hematopoietic system achieved 90%-96% chimerism ( Figures  S3A-S3C ). Infected WT/Il1b À/À chimeras developed cell proliferation and Th cell differentiation similar to control WT/WT mice, indicating that LC-derived IL-1b is not required for Th17 cell induction ( Figures 3C and 3D ). In contrast, Th17 cell differentiation was reduced in WT/Il6 À/À chimeras, indicating that LC-derived IL-6 is required for Th17 cells (Figures 3E and 3F) . Moreover, Th17 cell differentiation was intact in Il6 À/À / WT mice in which LCs were the only IL-6-sufficient hematopoietic cell type ( Figure 3H ). Thus, IL-6 derived from LCs is necessary for Th17 cell induction during skin infection.
LC-Derived IL-6 Requires Dectin-1 Engagement A subset of patients with chronic mucocutaneous candidiasis (CMC) have mutations in the transcription factor STAT3, which acts downstream of the IL-6 receptor (McDonald, 2012) . Patients with Dectin-1 polymorphisms also suffer from CMC and have decreased IL-6 production by their peripheral blood mononuclear cells (PBMCs) (Ferwerda et al., 2009 ). In addition, budding yeast engages Dectin-1 whereas yeast but not pseudo-hyphae trigger IL-6 secretion in human PBMCs (Armitage et al., 2011) . Because Th17 cell differentiation depends on LC-derived IL-6, we next sought to determine whether Th17 cell differentiation required engagement of Dectin-1 on LCs. We took advantage of a clinical isolate, s20175.016, that has similar virulence as SC5314 but its immune recognition is independent of Dectin-1 (Figure S4A and S4B; Marakalala et al., 2013) . Antigen was targeted to LCs in huLangerin mice using 2G3-Ea followed by infection with SC5314 or s20175.016. As expected, CD4 + T cell expansion and Th1 cell differentiation were comparable between the two experimental groups but Th17 cell differentiation was reduced in mice infected with s20175.016 (Figures 4A and 4B) . Analysis of LCs isolated from the skin draining lymph nodes 3 days after infection revealed a large reduction in IL-6 production in mice infected with s20175.016 compared with SC5314 ( Figures 4C and S5 ). Moreover, intradermal injection of 1 mg recombinant IL-6 at the time of infection restored Th17 cell differentiation ( Figure 4D ). Finally, we directly explored the necessity of Dectin-1 signaling by comparing the host response to C. albicans infection in Dectin-1 deficient (Clec7a À/À ) mice.
Whereas WT and Clec7a À/À mice strains exhibited similar T cell expansion, Dectin-1-deficient host demonstrated diminished Th17 cell responses ( Figures 4E and 4F ). Thus Th17 cell differentiation requires engagement of Dectin-1 on LCs that results in increased expression of IL-6.
Absence of Dectin-1 Ligands Prevent Th17 Cell Induction by Dermal DCs
To examine the function of dermal DC subsets in the induction of Th17 cell responses, we first compared expression of Dectin-1 by each subset. Dectin-1 is expressed by LCs and CD11b + dDCs but not by CD103 + dDCs ( Figure 5A ). The absence of Dectin-1 on CD103 + dDCs is consistent with our previous observation that this DC subset was required for Th1 but not Th17 cell induction (Igyá rtó et al., 2011 Kumamoto et al., 2013) . DT-treated Mgl2-DTR mice have reduced Th17 cell differentiation that could result from deletion of either subset (Figure S6D ). To selectively ablate CD11b + dDCs, we generated Mgl2-DTR/WT chimeric mice ( Figure S6C ). Notably, antigenspecific T cell expansion and Th cell phenotype was unaltered in DT-treated Mgl2-DTR/WT mice infected with Eno1-Ag, indicating that CD11b + dDCs are not required for Th17 cell differentiation ( Figures 5B and 5C ). To determine whether this DC subset could be sufficient for Th17 cell induction, we generated LC À 3 
Batf3
À/À mice, we considered the possibility that CD11b + dDCs have limited access to antigen during an epicutaneous infection. In wild-type mice, we compared epicutaneous with dermal infection by using the same inoculum of Eno1-Ag. Though T cell expansion and Th1 cell differentiation was similar, Th17 cell differentiation was greatly reduced in response to intradermal infection ( Figures 6A and 6B) . Induction of Th17 cell was also absent in response to an i.v. systemic infection (Figures S7A and S7B) . Notably, addition of the Dectin-1 ligand, curdlan, with the intradermal inoculation rescued the Th17 cell response, suggesting that Dectin-1 ligation does not occur in the dermis during C. albicans infection but that CD11b + dDCs do have the capacity to induce Th17 cells ( Figure 6C ). During epicutaneous C. albicans infection, yeast are found on the epidermis and invasive filamentous forms in the dermis ( Figure 6D ; Gow et al., 2012) . To test whether hyphal forms of C. albicans are unable to induce Th17 cells due to the absence of Dectin-1 ligands, we infected mice epicutaneously with Hwp1-Ag with the addition of exogenous curdlan or vehicle ( Figure 6E ). The addition of Dectin-1 ligands rescued the ability of antigen expressed by hyphal forms of C. albicans to generate Th17 cell responses.
Compartmentalization of Th Cell Responses
The ability of C. albicans to induce Th17 cells in response to an epidermal infection and Th1 cells in response to an invasive infection raises the possibility that specific Th cell phenotypes could provide protection at distinct anatomical sites. To test this hypothesis, we epicutaneously infected WT, Il6 À/À , and Batf3 À/À mice with Eno1-Ag. As expected, Il6 À/À mice generated a robust Th1 cell response in the absence of Th17 cells and Batf3 À/À mice developed a strong Th17 cell response in the absence of Th1 cells ( Figure 7A ). Separate cohorts of mice were re-challenged by skin infection 9 days after spontaneous clearance of the primary infection. The number of colony forming units (CFUs) found in naive mice challenged with SC5314 was similar in all three groups (open symbol) ( Figure 7B ). Notably, though IL-6 is an innate cytokine important for resistance to systemic C. albicans infection, naive Il6 À/À mice did not develop an exaggerated cutaneous infection (van Enckevort et al., 1999) . Secondarily infected (closed symbols) WT mice had an approximate 10-fold increase in fungal resistance. In contrast, Batf3
mice had approximately 100-fold increase in pathogen resistance and Il6 À/À mice showed no increased resistance to reinfection compared to naive mice ( Figure 7B ). To test whether this was a CD4 + -T-cell-dependent process, we purified CD4 + T cells from Il6 À/À and Batf3 À/À mice infected 7 days earlier and adoptively transferred them into naive hosts that were then skin infected. Naive recipients of CD4 + T cells from Batf3
but not Il6 À/À mice were protected against a cutaneous infection.
Thus, the Th17 cells that arise in response to a cutaneous C. albicans infection provide protection against subsequent skin challenges ( Figure 7C ). In contrast, systemic challenge of previously skin-infected mice by i.v. inoculation revealed protection in WT and Il6 À/À mice but not in Batf3 À/À mice ( Figure 7D ). Similarly, adoptive transfer of CD4 + T cells from skin-infected Il6 À/À mice but not
Batf3
À/À mice into naive recipients conferred protection against systemic candidiasis ( Figure 7E ). Thus, mice with expanded numbers of Th17 cell effectors were more resistant to cutaneous C. albicans challenge whereas mice with expanded numbers of Th1 cells were more resistant to systemic challenge. We conclude that Th cell effector cells appear to be functionally compartmentalized, with Th17 cells providing skin protection and Th1 cells providing systemic protection.
DISCUSSION
Herein we have demonstrated that the differentiation of Th17 cells in response to C. albicans skin infection occurs during infection with C. albicans yeast but not pseudo-hyphae. Th17 cell induction required the engagement of Dectin-1 and subsequent expression of IL-6 by Langerhans cells. CD11b + dDCs expressed Dectin-1 but were neither necessary nor sufficient for Th17 cell responses. The inability of C. albicans in the dermis to induce Th17 cells resulted from a morphologic change from yeast to pseudo-hyphae that occurred during invasion and could be rescued by the addition of exogenous Dectin-1 ligand. Finally, we found that Th17 cell expansion provided protection against cutaneous but not systemic challenge whereas the Th1 cell expansion provided protection against systemic but not cutaneous challenge.
The ability of C. albicans morphology to dictate immune responses has been an area of considerable controversy. Our 
of TEa cells isolated from skin draining lymph nodes 4 days after infection is shown. Neg represents mock infected WT mice (triangles). (C) Expression of the indicated cytokines from PMA and ionomycin TEa cells in (B) is shown. (D and E) Expansion (D) and cytokine production (E) by TEa cells in WT (white) or LC À 3 Batf3 À/À (black) mice 4 days after infection with Eno1-Ag is shown.
Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least three independent experiments. See also Figure S6 . data using mutants that are locked into yeast (chp1/cph1) or pseudo-hyphae (tup1/tup1) as well as a recombinant C. albicans strain in which model antigens are expressed exclusively by pseudo-hyphae (Hwp1-Ag) demonstrate that, in vivo, C. albicans yeast but not pseudo-hyphae induce Th17 cell differentiation. This is consistent with the finding that the ligand for Dectin-1 is largely accessible in the scars or patches of budding yeasts (Cabib and Bowers, 1971; Gantner et al., 2005; Gow et al., 2012) . Using in vitro methods, others have found that C. albicans pseudo-hyphae can induce Dectin-1-mediated Th17 cell differentiation through an IL-1b-dependent mechanism as well as induce Th2 or Tr1 cell responses (Cheng et al., 2011; d'Ostiani et al., 2000) . These data can be reconciled by the differing availability in vitro versus in vivo of Dectin-1 ligands on morphologic forms of C. albicans (Marakalala et al., 2013) . Differentiation of Th17 cells requires TGF-b as well as IL-1b and/or IL-6 depending on the site of immunization (Hu et al., 2011) . Using total cytokine-deficient mice, we found that Th17 cell development during skin infection is dependent on both IL-1b and IL-6. By generating mice with LC-selective defects of TGF-b1, IL-1b, and IL-6, we found that LCs were a non-redundant source of only IL-6. Though LC-derived IL-1b and TGF-b were not required, there are many other cellular sources of these cytokines that could either be the primary source during infection or provide functionally sufficient quantities in the absence of LCs. Notably, specific ablation of MyD88 in LCs resulted in reduced expression of IL-6 and defective Th17 cell differentiation during C. albicans infection, suggesting that IL-1b could potentiate IL-6 expression by LCs . It is important to note that Dectin-1 also cooperates with toll-like receptor-2 (TLR-2) and TLR-4 to mount pro-inflammtory responses (Ferwerda et al., 2008; Gantner et al., 2003) . In addition to any possible role for IL-1b, we found that engagement of Dectin-1 on LCs was required for optimal IL-6 expression. Infection with a Dectin-1-independent strain induced only low expression of IL-6 by LCs that failed to induce Th17 cell differentiation. Addition of exogenous IL-6 was able to rescue the Th17 cell phenotype. Similarly, patients with Dectin-1 deficiency suffer from CMC and have defective IL-6 production in response to C. albicans (Ferwerda et al., 2009 ). Thus, we have defined a model in which interaction of LCs with C. albicans yeast results in a Dectin-1-dependent expression of IL-6 that is required for Th17 cell differentiation during skin infection.
In the dermis, Dectin-1 is expressed by CD11b + dDCs but not CD103 + dDCs. The absence of Dectin-1 on CD103 + dDCs is consistent with our prior observations that these cells were required for induction of Th1 cell differentiation (Igyá rtó et al., 2011) . Despite expressing Dectin-1, CD11b + dDCs were neither necessary nor sufficient for optimal induction of Th17 cell responses to either an epicutaneous or dermal infection with C. albicans. Importantly, during a dermal infection or an epicutaneous infection with Hwp1-Ag, situations in which antigen bypasses LCs in the epidermis, efficient Th17 cell differentiation was restored by addition of the exogenous Dectin-1 ligand, curdlan. CD11b + dDCs have been reported to drive Th2 cell responses to papain immunization and nippostrongylus infection ( Gao et al., 2013; Kumamoto et al., 2013) . Our data suggest that in addition to Th2 cells, these cells might also have the capacity to induce Th17 cell differentiation given the appropriate adjuvant. Indeed, similar IRF4 + CD11b + DCs can produce Th17 cell responses in other tissues (Persson et al., 2013; Schlitzer et al., 2013) . Thus, the inability of CD11b + dDCs to induce Th17 cells is not intrinsic to CD11b + dDCs but results from the morphologic change of C. albicans into pseudo-hyphae as it invades into the dermis and probably represents an adaptation of C. albicans to evade immune responses. Humans are chronically exposed to C. albicans and circulating anti-Candida CD4 + Th1 and Th17 cells have been identified (Zielinski et al., 2012) . The importance of adaptive responses to C. albicans has been demonstrated by the high prevalence of mucocutaneous candidiasis in patients with Th17 cell defects (e.g., hyper IgE syndrome) and some immunodeficiencies (e.g., HIV) (McDonald, 2012) . Our results as well as the work of others has found that adaptive responses to C. albicans infection in mice are also dominated by Th1 and Th17 cells and provide protection from secondary infection, thus mimicking the response seen in humans (Conti and Gaffen, 2010; Eyerich et al., 2008; Huppler et al., 2012; Puel et al., 2011; Zielinski et al., 2012) . We found that Batf3 À/À mice lacking CD103 + dDCs and Il6 À/À mice developed either greatly exaggerated or absent Th17 cell development, respectively, without any alteration in skin innate responses to C. albicans. Secondary skin infection of mice with exaggerated Th17 cell expansion resulted in significant increase in protection compared with mice lacking Th17 cells that showed no evidence of protection. Mice receiving exogenous C. albicans-primed Th17 but not Th1 cells also were protected from skin infection. Thus, consistent with the welldocumented role of Th17 cells in protection from CMC, Th17 cell expansion provided protection from secondary skin infection (Eyerich et al., 2008; McDonald, 2012) . In addition, the ability of C. albicans yeast to drive Th17 cell responses and provide protection argues against the concept that the failure of yeast to generate Th17 cell is a mechanism that maintains C. albicans commensalism (Bonifazi et al., 2009; Romani, 2011) . Notably, we found that Th17 cell expansion failed to provide protection from systemic infection. Rather, enhanced protection from systemic challenge occurred in Il6 À/À mice that developed exaggerated Th1 cells as well as naive recipients of primed CD4 + T cells isolated from infected Il6 À/À mice. Notably, this protection developed despite an enhanced susceptibility to primary disseminated C. albicans that occurs in Il6 À/À mice (van Enckevort et al., 1999) . It was also independent of the phenomenon of reprogrammed monocytes that can provide protection from systemic infection through an IL-6-dependent mechanism (Quintin et al., 2012) . Notably, patients with mutations in STAT1 that reduce signaling of IFN-g develop increased rates of systemic infection with C. albicans and other fungi (Puel et al., 2011; Sampaio et al., 2013) . We speculate that IFN-g or granulocyte-macrophage colony-stimulating factor (GM-CSF) derived from Th1 cell effectors might enhance the anti-Candida responses by promoting increased NK and/or macrophage activity (Bä r et al., 2014) . In summary, these data reveal a role for C. albicans morphology and interaction with a single DC subset for the generation of Th17 cell responses. In addition, the tissue-selective , or SC5314-infected Batf3 À/À mice 7 days after infection and adoptively transferred into naive WT recipients. Recipients were skin infected with SC5314 1 day after transfer and CFU was assessed at the infected area 2 days later.
(D) As in (B) except that mice were challenged by i.v. infection with 10 5 SC5314.
(E) As in (C) except that mice were challenged by i.v. infection with 10 5 SC5314. Fungal burdens in the kidneys expressed as CFU/g is shown.
Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. 
Clec7a
À/À mice have been previously described Kaplan et al., 2005; Kissenpfennig et al., 2005; Kumamoto et al., 2013; Taylor et al., 2007; Welty et al., 2013) . Il1b À/À and Il6 À/À mice were purchased from The Jackson Laboratory. C57BL/6 and B6-Ly5.2/Cr were purchased from the National Cancer Institute or Charles River laboratories. CD90.1 Rag1 À/À CD4 + TEa TCR-transgenic mice that recognize Ea 50-66 in I-A b on C57BL/6 backgrounds were also used (Grubin et al., 1997) . All experiments were performed with 6-to 12-week-old and sex-matched mice. Mice were housed in microisolator cages and fed irradiated food and acidified water. The University of Minnesota institutional care and use committee approved all mouse protocols.
Generation and Testing of Bone Marrow Chimeric Mice 6-week-old cytokine-deficient, wild-type C57BL/6 or Ly5.2 congenically marked mice were irradiated with X-ray irradiator as previously described. The mice received two split doses at 500 cGy each. The following day, 5 3 10 6 bone marrow cells isolated from specified mice were injected intravenously. Mice were rested for at least 6 weeks prior to experiments. The efficiency of chimerism was determined by flow cytometry of congenic markers on PBMC, lymph node, and epidermis.
DC Depletion with Diphtheria Toxin
Mgl2-DTR and huLangerin-DTR mice were i.p. injected with 1 mg of diphtheria toxin (List Biological Laboratories) 2 days before infection, as previously described (Bobr et al., 2010; Igyá rtó et al., 2011) .
Tamoxifen Treatment
Tamoxifen (Sigma Aldrich) was dissolved in corn oil (Sigma Aldrich) and 10% ethanol and was administered 5 consecutive days by i.p. injection at 0.05 mg/g of mouse weight.
Antibodies
Fluorochrome-conjugated antibodies to CD4 (GK1.5), CD11b (M1/70), CD11c (N418), CD45.1 (A20), CD45.2 (104), CD90.1 (OX-7), CD103 (2E7), I-A/I-E (M5/114.15.2), Dectin-1 (RH1), IFN-g (XMG1.2), IL-10 (JES5-16E3), and IL-17A (TC11-18H10.1) were purchased from BioLegend. Anti-mouse Langerin (L31), IL-17F (18F10), IL-22 (1H8PWSR), and Foxp3 (FJK-16S) were acquired from eBioscience.
Adoptive T Cell Transfer T cells were adoptively transferred as previously described (Igyá rtó et al., 2011) . In brief, skin draining lymph nodes, spleen, and mesenteric lymph node of TEa mice were disrupted through a cell strainer, washed with sterile HBSS, and labeled with CFSE (Invitrogen) in accordance with the manufacturer's instructions. The cells after two washes were resuspended in sterile PBS at a concentration of 1 3 10 6 cell/ml and 300 ml (3 3 10 5 cells) were injected intravenously into recipients.
In certain experiments, single-cell suspension from secondary lymphoid organs from either naive wild-type or skin-infected Il6-or Batf3-deficient mice were obtained. CD4 + T cells were magnetically isolated at >95% purity (STEMCELL Technologies) according to manufacturer's directions. A total of 5 3 10 6 million purified CD4 + T cells were transferred into naive hosts in 300 ml PBS.
Flow Cytometry
Single-cell suspensions of epidermal cells were obtained as previously defined (Kaplan et al., 2005) . In brief, skin from ear or trunk were obtained and incubated for 2 hr at 37 C in 0.3% trypsin (Sigma-Aldrich) in 150 mM NaCl, 0.5 mM KCl, 0.5 mM glucose. The epidermis was physically separated from the dermis. Dermal cells were obtained from whole flank skin. Samples were minced and incubated for 2 hr at 37 C in collagenase XI (4,830 U/ml, Sigma), hyaluronidase (260 U/ml, Sigma), DNase (0.1 mg/ml, ICN), 10 mM HEPES (Sigma) in RPMI (Invitrogen). The resulting cells were filtered through a 40 mm filter. Lymph node (axillary, brachial, and inguinal) and spleen cells were incubated in 400 and 150 U/ml Collagenase D for preparation of dendritic cells or smashed through a filter for lymphocytes (Roche Applied Science), respectively, for 90 min prior to erythroid cell lysis in ACK buffer (Biowhittaker). Single-cell suspensions were pretreated for 10 min at 4 C with 2.4G2 except when anti-Rat secondaries were used, in which case cells were blocked with mouse Ig (Sigma). For evaluating cytokine expression, cells were incubated for 5 hr in complete IDMEM supplemented with PMA (50 ng/ml) and ionomycin (1.5 mM; Sigma-Aldrich), with GolgiStop (BD PharMingen) added for the final 4 hr. The intracellular cytokine staining was performed with BD Bioscience Cytofix/Cytoperm kit (BD Biosciences) in accordance with the manufacturer's instructions. Samples were analyzed on LSR-II flow cytometers (BD Biosciences). Data were analyzed with FlowJo software (TreeStar). Detection of 2W1S-specific CD4 + T cells was performed as published with an I-Ab-2W1S tetramer (a kind gift of M. Jenkins) after ex vivo stimulation of secondary organs as previously described (Moon et al., 2007) . . RNA was isolated with an RNeasy Mini Kit (QIAGEN) and quantified from Nanodrop readings (NanoDrop). cDNA was generated with a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). TaqMan Gene Expression Master Mix and TaqMan Gene Expression Assays for IL-1, IL-6, and IL-12p40 was used. ABI Prism 7900HT (Applied Biosystems) were used to complete the qPCR. All kits were completed according the manufacturer's instructions. All Ct values were normalized to HPRT expression and are shown as 2
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ÀDCt to naive.
Candida albicans Strains
Recombinant C. albicans used in this study was derived from SC5314 and was designed as previously described (Fonzi and Irwin, 1993; Igyá rtó et al., 2011) . They were grown in rich medium at 30 C (YPAD) or in synthetic complete medium. Escherichia coli strain XLI-blue (Stratagene), growth conditions, DNA manipulations, and primer design and synthesis were essentially as described previously. Transformants were selected on YPAD medium containing 400 mg/ml nourseothricin and were screened by PCR with oligonucleotide primers listed ( Figure S2C ). In brief, strain Hwp1-eGFP-Ag was constructed as follows: plasmid pMG2268 was PCR with Primers 875 and 5266. PCR product was transformed into wild-type strain SC5314 by standard methods (Igyá rtó et al., 2011) . Transformants were selected on YPAD medium containing 400 mg/ml nourseothricin. Integration at the HWP1 locus was confirmed with two primers (877/3290) confirming integration of GFP-antigen at HWP1. C. albicans strains s20175.016, yeast locked strain (JKC19), and filament locked strain (BCa2-9) were kindly provided by Dr. Neal Gow (University of Aberdeen) (Braun and Johnson, 1997; Liu et al., 1994; Maccallum, 2012; Marakalala et al., 2013) . Growth of fungi occurred after inoculation of a colony at 30 C in YPAD overnight and, the next day, diluted 1:10 and cultured either at 30 C in YPAD until OD 600 reached 1.5 for yeast morphology or at 37 C in RPMI with 10% FBS for 3 hr for filamentous forms.
Infection Models
The skin infection was performed as described (Igyá rtó et al., 2011) . In brief, mice were first anesthetized with a mixture of ketamine and xylazine (100/ 10 mg/kg body weight), shaved on the back with electric clipper, and chemically depilated with Nair hair remover (Church & Dwight) per the manufacturer's instructions. The stratum corneum was removed with 15 strokes with 220 grit sandpaper (3M). After washing with sterile PBS, 2 3 10 8 C. albicans in 50 ml of sterile PBS was applied to the skin. In some experiments, same dose of C. albicans or 50 mg curdlan was injected intradermally spaced over 10 sites on the back. Where indicated, recombinant murine IL-6 (BioLegend) was injected into 4 different sites in the dorsum of the mice intradermally at a total dose of 1 mg per mice. i.v. infections with Eno1-Ag and Hwp1-Ag for assessment of T cell expansion were performed at 3 3 10 5 CFU in PBS.
In re-challenge experiments, previously mock or epicutaneously infected mice were challenged with 1 3 10 6 CFU C. albicans by being intradermally injected into a single site or by 1 3 10 5 CFU intravenously. Skin and kidneys were harvest from mice 3 days later and homogenized and serially diluted onto YPAD plates and incubated at 30 C for 24-48 hr to assess the number of colony-forming units.
LC Targeting with Anti-huLangerin Anti-human-Langerin antibodies (2G3) conjugated to antigen were generated and administered as previously described (Igyá rtó et al., 2011) . In brief, WT and huLangerin-DTR mice were immunized by intraperitoneal injection of 1.0 mg of 2G3-Ea in 100 ml of sterile PBS. Six hours later, the mice were infected with the pathogen strains noted as above.
Histology
Immunofluorescence on ear epidermis was performed as previously described (Kaplan et al., 2005) . Images were captured with a microscope (DM5500; Leica) with digital system and LAS AF software (v.1.5.1). Periodic Acid-Schiff (PAS) staining for fungal invasion was performed 2 days after infection with SC5314 on formaldehyde-fixed frozen sections with commercial PAS staining kit (Sigma-Aldrich). 
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